Evidence map›Paper›PMID 15616336›Full record

ArticleAntimicrobial agents and chemotherapy2005

Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing.

Marjo Haanperä, Pentti Huovinen, Jari Jalava

Abstract readEvaluation Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Expanding the Scope of Protein Synthesis Using Modified Ribosomes.Journal of the American Chemical Society · 2019
    Article
  4. Gene subtype analysis ofExperimental and therapeutic medicine · 2018
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. From structure to function: the ecology of host-associated microbial communities.Microbiology and molecular biology reviews : MMBR · 2010
    Review
  12. Article
  13. Article
  14. Article
  15. Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2009
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marjo HaanperäHuman Microbial Ecology Laboratory, National Public Health Institute, Kiinamyllynkatu 13, FI-20520 Turku, Finland. marjo.haanpera@ktl.fi
Pentti Huovinen
Jari Jalava

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A pyrosequencing method for detection and quantification of macrolide resistance mutations at positions 2058 and 2059 (Escherichia coli numbering) of the 23S rRNA gene is described. The method was developed and tested for Streptococcus pneumoniae, Streptococcus pyogenes, Mycobacterium avium, Campylobacter jejuni, and Haemophilus influenzae.

Indexed as

MutationAnti-Bacterial AgentsBacteriaBase SequenceDiphosphatesDNA, RibosomalDrug Resistance, BacterialGenes, rRNAHumansMacrolidesMicrobial Sensitivity TestsMolecular Sequence DataPolymerase Chain ReactionRNA, Ribosomal, 23SSequence Analysis, DNAAnti-Bacterial AgentsDiphosphatesDNA, RibosomalMacrolidesRNA, Ribosomal, 23S

Identifiers

PMID15616336
PMCPMC538907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.